Friday, December 13, 2013

Email to J&J Chief Compliance Officer

From: RDShatt@aol.com
To: kcurry@its.jnj.com
CC: pat@ethics.org, KDarcy@theecoa.org, roy.snell@corporatecompliance.org
Sent: 12/13/2013 8:11:59 P.M. Central Standard Time
Subj: J&J $2.2B fine; Health Care Compliance and Ethics

Ms. Kris Curry
Vice President, Health Care Compliance
Pharmaceuticals Group
Johnson & Johnson

Dear Ms. Curry,

I wish to use the recent $2.2 billion fine that the Justice Department imposed on Johnson & Johnson (see Wall Street Journal article here) as a case example that is supportive of my contention that there is a serious shortcoming in how the mainstream corporate ethics and compliance community has been pursuing and implementing its mission program for the past twenty years.

The foregoing contention is set out in numerous entries in my blog How To Combat Plaintiffs' Lawyers. Recent entries I would particularly call to your attention are Are Ethics & Compliance Sidelined? and this email I sent to the Ethics Resource Center a month ago. Additional relevant entries in my blog can be easily found by clicking on links to other entries you encounter and otherwise through my blog's organization.

I have started my discussion of the Johnson & Johnson case here. I am very interested in conversing with you about the case if you would care to indulge me. If not, I will understand.

Thank you for your attention to this email.

Sincerely,

Robert Shattuck
Birmingham, AL

No comments: